The European challenges of funding orphan medicinal products

Official Journal of the European Communities

Analytical Proceedings · 1984 · 4K citations

European Community Law, European Law, Arts +5

Assessing the economic challenges posed by orphan drugs

Michael Drummond, David A. Wilson, Panos Kanavos et al. · International Journal of Technology Assessment in Health Care · 2007 · 265 citations

Drug Policy, Policy Analysis, Harm Reduction +18

Pricing and reimbursement of orphan drugs: the need for more transparency

Steven Simoens · Orphanet Journal of Rare Diseases · 2011 · 250 citations · Full text

Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?

Wills Hughes-Wilson, Ana Luiza do Rosário Palma, Ad Schuurman et al. · Orphanet Journal of Rare Diseases · 2012 · 163 citations · Full text

Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group

Sandra Nestler-Parr, D Korchagina, Mondher Toumi et al. · Value in Health · 2018 · 133 citations · Full text

Disease Diagnosis, Epidemiology, Engineering +12